| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.02 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.02 |
| mRNA | OSU-03012 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.65 | 0.02 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.02 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.079 | 0.03 |